CD BioGlyco, a biotechnology company dedicated to developing a one-stop service in the field of glycomics, now provides professional and high-quality glycan derivatization services to give scientific assistance for researchers in need.
Carbohydrates only absorb light at low wavelengths, which makes UV and fluorescence detection less sensitive. Additionally, low sensitivity in glycan analysis is a drawback for amperometry and refractive index detection. Glycan derivatization is therefore essential in glycomics.
Now, CD BioGlyco offers expert and superior glycan derivatization services, such as end-reduction derivatization, hydroxyl derivatization, and sialic acid derivatization, based on years of experience in the glycobiology sector.
Reducing End Derivation Service
In the last ten years, CD BioGlyco has consistently enhanced experimental methods for glycan structure identification and quantification. For glycan fluorescence detection, the most widely used reducing end tags are 2-aminobenzamide (2-AB), 2-amino benzoic acid (2-AA), procainamide, and 8-aminopyrene-1,3,6-trisulfonic acid (APTS). Both the reduction of the free reducing end and the fluorescence labeling at the reducing end are efficient techniques.
CD BioGlyco has developed various hydroxyl group derivatization methods for the analysis of glycans including methylation/esterification/deoxygenation of hydroxyl groups with the help of mass spectrometry and other detection techniques.
A wide range of strategies are employed for the analysis of sialic acids: sialic acid derivatization at monosaccharide level; derivatization at free sialic acid level; sialic acid derivatization at N/O-glycan level; and sialic acid derivatization at glycosphingolipid level.
- Advanced and systematic experimental platform
- Powerful bioinformatics analysis software and professional technicians
- Simplified experimental operation process
- Detection and analysis of multiple experimental samples simultaneously
- Reproducible and less error-prone results
- Reliable after-sales service
CD BioGlyco’s glycan derivatization services are performed by highly experienced scientists using state-of-the-art equipment. The company offers a variety of customization options to meet the specific needs of its clients.
“We are excited to launch our new glycan derivatization services,” said Anna, one of the representative speakers at CD BioGlyco. “These services will provide our clients with a powerful tool for the detection and analysis of complex glycans.”
CD BioGlyco’s glycan derivatization services are available to academic researchers, pharmaceutical companies, and other biotechnology companies. For more information, please visit https://www.bioglyco.com/glycan-derivation-service.html.